Pawing Postdocs

Pawing Postdocs In your "Postdocs: Pawing out of Purgatory,"1 you have inadvertently misquoted me. You state that, "They point to the NIH, which doesn't provide benefits for its more than 3000 postdocs." That is incorrect--we do indeed provide excellent health insurance for all our postdocs as well as our predocs. The statement that I made, "That's not going to change. There are too many government regulations that restrict our ability to provide benefits," referred only to retirement benef

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In your "Postdocs: Pawing out of Purgatory,"1 you have inadvertently misquoted me. You state that, "They point to the NIH, which doesn't provide benefits for its more than 3000 postdocs." That is incorrect--we do indeed provide excellent health insurance for all our postdocs as well as our predocs. The statement that I made, "That's not going to change. There are too many government regulations that restrict our ability to provide benefits," referred only to retirement benefits since our trainees are not government employees.

Michael M. Gottesman, MD
Deputy Director for Intramural Research
National Institutes of Health

***

At the end of your story1 you suggest that organizations (presumably composed of postdocs) may be the only way to change the situation. This may be true, but if I belonged to such an organization I would think long and hard about revealing such membership on my CV when applying for a tenure-track ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Michael Gottesman

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide